Vestibular Schwannoma Management

Vestibular Schwannoma Management

Vestibular Schwannoma Management

On this page

VS 101 - Cerebellopontine Culprit

  • Benign tumor from Schwann cells of CN VIII; most common cerebellopontine angle (CPA) mass. CPA Anatomy and Cranial Nerve Origins
  • Origin: Typically inferior vestibular nerve > superior.
  • Genetics: NF2 gene mutation (Merlin protein) on chromosome 22q12.
    • Bilateral VS is pathognomonic for Neurofibromatosis Type 2 (NF2).
  • Growth: Slow, average 1-2 mm/year. 📌 Very Slow.

⭐ Progressive, unilateral sensorineural hearing loss (SNHL) is the hallmark symptom.

Symptoms & Signs - Hearing Hijinks

  • Unilateral/Asymmetric Sensorineural Hearing Loss (SNHL): Hallmark symptom (90-95%).
    • Typically progressive, insidious onset; initially affects high frequencies.
    • Sudden SNHL can occur in ~10-15% of patients.
  • Unilateral Tinnitus: Common (70%); often first symptom, may precede SNHL. Can be ringing, buzzing.
  • Poor Speech Discrimination: Disproportionately worse than pure tone audiometry (PTA) findings.

    ⭐ Rollover phenomenon: Speech discrimination scores significantly decrease at higher sound intensities, a classic sign.

  • Aural fullness: Sensation of pressure or blockage in the ear.

Diagnosis Decoded - Scan Secrets

  • MRI with Gadolinium (Gd) contrast: Gold standard investigation.
    • T1-weighted + Gd: Shows intensely enhancing lesion.
    • T2-weighted: Tumor hyperintense; delineates Internal Auditory Canal (IAC)/Cerebellopontine Angle (CPA) anatomy.
  • Hallmark Sign:
    • "Ice Cream Cone" Appearance: Tumor in CPA extending into a widened IAC. Vestibular Schwannoma MRI Axial T1 Contrast
  • Other Modalities:
    • CT (Bone window): Shows IAC widening if MRI is unavailable/contraindicated.
    • Audiometry: Asymmetric Sensorineural Hearing Loss (SNHL) is the key clinical finding prompting imaging.

⭐ Bilateral vestibular schwannomas are diagnostic of Neurofibromatosis Type 2 (NF2).

Management Modalities - Treatment Triangle

Core strategies for Vestibular Schwannoma (VS) involve a "treatment triangle":

  • Observation (Watchful Waiting/Active Surveillance):
    • Serial MRI for small, asymptomatic/mildly symptomatic tumors.
    • Often for elderly or comorbid patients.
  • Microsurgery:
    • Goal: Tumor removal, facial/cochlear nerve preservation.
    • Approaches: Translabyrinthine, Retrosigmoid, Middle Cranial Fossa (MCF).
    • Indicated for larger tumors, significant symptoms, or younger patients.
  • Radiosurgery/Radiotherapy (SRS/SRT):
    • E.g., Gamma Knife, CyberKnife.
    • Goal: Arrest tumor growth, preserve function.
    • For smaller tumors (<3 cm), growing tumors, or poor surgical candidates.

⭐ > For VS <3 cm, SRS offers high tumor control rates with functional preservation.

Surgical Strikes & Radio Rays - Scalpels & Beams

  • Surgery: Max safe removal; preserve CN VII, hearing.
    • Approaches:
      • Translabyrinthine (TL): Sacrifices hearing. Large tumors / poor hearing. Good CN VII access.
      • Retrosigmoid (RS): Hearing preservation possible. CPA tumors ± IAC extension.
      • Middle Cranial Fossa (MCF): Best hearing preservation. Small (<1.5 cm) intracanalicular tumors.
    • IONM essential for CN VII.
  • Stereotactic Radiosurgery (SRS): e.g., Gamma Knife.
    • Tumors <3 cm (ideal <2.5 cm), elderly, unfit, patient choice.
    • Goal: Growth arrest (control). Dose: 12-13 Gy (marginal).
    • Non-invasive. Tumor remains. Risks: delayed CN palsies, ↓hearing. Surgical approaches for Vestibular Schwannoma

⭐ Gross total resection (GTR) is aimed for, but subtotal resection (STR) followed by SRS is an option to preserve facial nerve function.

High‑Yield Points - ⚡ Biggest Takeaways

  • Vestibular Schwannoma (VS) is the most common Cerebellopontine Angle (CPA) tumor, arising from Schwann cells of CN VIII.
  • Progressive unilateral sensorineural hearing loss (SNHL) and tinnitus are classic early symptoms.
  • MRI with gadolinium contrast is the gold standard diagnostic test.
  • Management options include observation (for small/asymptomatic tumors), microsurgical excision, and stereotactic radiosurgery (SRS).
  • Preservation of facial nerve (CN VII) function is a primary surgical goal.
  • Bilateral vestibular schwannomas are pathognomonic for Neurofibromatosis Type 2 (NF2).

Practice Questions: Vestibular Schwannoma Management

Test your understanding with these related questions

The most common tumor of the cerebellopontine angle is -

1 of 5

Flashcards: Vestibular Schwannoma Management

1/10

Acoustic neuroma is seen in middle age in _____

TAP TO REVEAL ANSWER

Acoustic neuroma is seen in middle age in _____

both sexes equally (females/males)

browseSpaceflip

Enjoying this lesson?

Get full access to all lessons, practice questions, and more.

Start Your Free Trial